Compare UTI Healthcare Fund vs HDFC Pharma And Healthcare Fund
UTI Healthcare Fund
EquitySectoral-Pharma
HDFC Pharma And Healthcare Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
4.0
5.0
Min SIP Amount
₹500
₹100
Expense Ratio
2.21
2.12
NAV
₹379.49
₹22.25
Fund Started
01 Aug 2005
14 Sep 2023
Fund Size
₹1429.84 Cr
₹3501.37 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 1%, if redeemed within 30 days.
1 Year
13.25%
22.21%
3 Year
22.29%
29.05%
5 Year
15.18%
-
Equity
94.12%
96.77%
Cash
5.85%
3.23%
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 7.62% |
Divi's Laboratories Ltd. | 6.15% |
Dr. Reddy's Laboratories Ltd. | 5.24% |
Ajanta Pharma Ltd. | 4.81% |
Gland Pharma Ltd. | 4.06% |
Alkem Laboratories Ltd. | 3.70% |
Apollo Hospitals Enterprise Ltd. | 3.03% |
Caplin Point Laboratories Ltd. | 3.02% |
Global Health Ltd. | 2.96% |
Lupin Ltd. | 2.89% |
Name | Assets |
|---|---|
Divi's Laboratories Ltd. | 9.39% |
Sun Pharmaceutical Industries Ltd. | 8.28% |
Alkem Laboratories Ltd. | 4.64% |
Cipla Ltd. | 4.15% |
Apollo Hospitals Enterprise Ltd. | 3.69% |
Torrent Pharmaceuticals Ltd. | 3.65% |
Max Healthcare Institute Ltd. | 3.61% |
Aster DM Quality Care Ltd. | 3.56% |
Lupin Ltd. | 3.55% |
Neuland Laboratories Ltd. | 3.24% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
Launch Date
01 Aug 2005
14 Sep 2023
